← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jun 1, 2007
Tonix Pharmaceuticals— Founded
2010s
- Jan 28, 2016
sumatriptan— Marketing Organization
- Jan 28, 2016
sumatriptan— NDA Secondary Org
Drugs by trial phase (12 distinct, 32 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (50)
- NCT07204080CollaboratorPhase 2Jan 1, 2026
- NCT06636786CollaboratorPhase 2Oct 31, 2024
- NCT06045793OfficialPhase 2Dec 11, 2023
- NCT06045793Study directorPhase 2Dec 11, 2023
- NCT06045793Lead sponsorPhase 2Dec 11, 2023
- NCT05686408Lead sponsorPhase 2Mar 2, 2023
- NCT05686408Study directorPhase 2Mar 2, 2023
- NCT05679908Study directorPhase 2Dec 6, 2022
- NCT05679908Lead sponsorPhase 2Dec 6, 2022
- NCT05679908OfficialPhase 2Dec 6, 2022
- NCT05472090Study directorPhase 2Aug 18, 2022
- NCT05472090Lead sponsorPhase 2Aug 18, 2022
- NCT05372887Study directorPhase 2Jun 30, 2022
- NCT05372887Lead sponsorPhase 2Jun 30, 2022
- NCT05273749Study directorPhase 3Apr 6, 2022
Details
- Founded
- New York, NY, US Jun 1, 2007
- Last known activity
- Jan 1, 2026